Safety of a 2-visit cluster schedule of venom immunotherapy in outpatients at risk of life-threatening anaphylaxis.
Sánchez-Machín
I
I
Allergy Service, Hospital Universitario NS Candelaria, Santa Cruz de Tenerife, Spain.
Moreno
C
C
González
R
R
Iglesias-Souto
J
J
Pérez
E
E
Matheu
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000209:etiology*; D001514:Bee Venoms / Q000008:administration & dosage* / Q000276:immunology; D002648:Child; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D012306:Risk
D001514:Bee Venoms